Zonera Hassan
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Corrigendum to "A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer" [Bioorgan. Chem. 119 (2022) 105505].
Journal: Bioorganic chemistry
Published: March 08, 2024
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: May 25, 2022
Mass spectrometry-based draft of the mouse proteome.
Journal: Nature methods
Published: January 17, 2022
RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells.
Journal: Frontiers in oncology
Published: December 01, 2021
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.
Journal: Cancer communications (London, England)
Published: September 04, 2021
A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer.
Journal: Bioorganic chemistry
Published: June 22, 2021
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype.
Journal: JCI insight
Published: May 12, 2021
Important role of Nfkb2 in the KrasG12D-driven carcinogenesis in the pancreas.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: January 29, 2021
HDAC2 Facilitates Pancreatic Cancer Metastasis.
Journal: Cancer research
Published: September 27, 2020
Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC.
Journal: Molecular oncology
Published: July 04, 2020
The SUMO pathway in pancreatic cancer: insights and inhibition.
Journal: British journal of cancer
Published: March 14, 2020
Last Updated: 09/26/2026